245 related articles for article (PubMed ID: 30463722)
1. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
Sinukumar S; Engineer R; Saklani A
Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
[TBL] [Abstract][Full Text] [Related]
6. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.
Ishihara S; Kanemitsu Y; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Sugihara K; Watanabe T
Int J Colorectal Dis; 2016 Jul; 31(7):1315-21. PubMed ID: 27240821
[TBL] [Abstract][Full Text] [Related]
7. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
8. S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection.
Kim HJ; Choi GS; Park JS; Park SY; Cho SH; Seo AN; Yoon GS
Surg Endosc; 2020 Jan; 34(1):469-476. PubMed ID: 31139999
[TBL] [Abstract][Full Text] [Related]
9. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
10. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
Hida K; Nishizaki D; Sumii A; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Arizono S; Uemura M; Hasegawa H; Kawada K; Morita S; Watanabe M;
Ann Surg Oncol; 2021 Oct; 28(11):6179-6188. PubMed ID: 34255243
[TBL] [Abstract][Full Text] [Related]
13. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
14. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
15. Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach.
Kim HJ; Choi GS; Park JS; Park SY; Lee HJ; Woo IT; Park IK
Surg Endosc; 2018 May; 32(5):2466-2473. PubMed ID: 29124406
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Surg; 2021 Dec; 21(1):441. PubMed ID: 34961494
[TBL] [Abstract][Full Text] [Related]
17. Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes.
Tsukada Y; Rullier E; Shiraishi T; Capdepont M; Sasaki T; Celerier B; Denost Q; Ito M
Colorectal Dis; 2023 Jun; 25(6):1153-1162. PubMed ID: 36932710
[TBL] [Abstract][Full Text] [Related]
18. Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer.
Kim HJ; Choi GS; Park JS; Park SY; Cho SH; Lee SJ; Kang BW; Kim JG
Oncotarget; 2017 Nov; 8(59):100724-100733. PubMed ID: 29246016
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prognostic significance of postoperative complications following lateral pelvic lymph node dissection for rectal cancer: results of the multicenter lateral node study in China.
Zhou S; Tang J; Mei S; Lou Z; Fu W; Feng B; Yang Y; Sun Y; Liu Q;
Jpn J Clin Oncol; 2022 Oct; 52(10):1150-1158. PubMed ID: 35858237
[TBL] [Abstract][Full Text] [Related]
20. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
Zhou S; Jiang Y; Liang J; Liu Q
World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
